Reported Jan 15, 2014 · Terminated

Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna,…

Watson Laboratories Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Watson Laboratories Inc · 132 Business Center Dr · Corona, CA · 92880-1724

Is this the product you have?

  • Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Salcette, Goa, 403 722 INDIA
  • Distributed byWatson Pharma Ltd, Parsippany, NJ 07054. NDC 0591-5513-05
Lot codes and dates
    • Lot # 244152A
    • exp 01/15
Amount recalled
4,439 bottles

Where it was sold

  • Nationwide

Why it was recalled

Presence of Foreign Substance; metal particulates were visually observed in the tablets.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Watson Laboratories Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Notice updated Aug 4, 2014 · Data as of Sep 19, 6:26 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.